Institute of Microbiology, Academy of Sciences of Czech Republic, Vídeňská 1083, CZ-14220 Praha 4, Czech Republic.
Carbohydr Res. 2011 Sep 6;346(12):1599-609. doi: 10.1016/j.carres.2011.04.043. Epub 2011 May 3.
This work reveals new structural relationships in the complex process of the interaction between activation receptors of natural killer cells (rat NKR-P1, human CD69) and novel bivalent carbohydrate glycomimetics. The length, glycosylation pattern and linker structure of receptor ligands were examined with respect to their ability to precipitate the receptor protein from solution, which simulates the in vivo process of receptor aggregation during NK cell activation. It was found that di-LacdiNAc triazole compounds show optimal performance, reaching up to 100% precipitation of the present protein receptors, and achieving high immunostimulatory activities without any tendency to trigger activation-induced apoptosis. In the synthesis of the compounds tested, two enzymatic approaches were applied. Whereas a β-N-acetylhexosaminidase could only glycosylate one of the two acceptor sites available with yields below 10%, the Y284L mutant of human placental β1,4-galactosyltransferase-1 worked as a perfect synthetic tool, accomplishing even quantitative glycosylation at both acceptor sites and with absolute regioselectivity for the C-4 position. This work insinuates new directions for further ligand structure optimisation and demonstrates the strong synthetic potential of the mutant human placental β1,4-galactosyltransferase-1 in the synthesis of multivalent glycomimetics and glycomaterials.
这项工作揭示了自然杀伤细胞(大鼠 NKR-P1、人 CD69)激活受体与新型双价碳水化合物糖模拟物相互作用这一复杂过程中的新结构关系。受体配体的长度、糖基化模式和连接体结构都经过了考察,以评估其从溶液中沉淀受体蛋白的能力,这模拟了 NK 细胞激活过程中受体聚集的体内过程。结果发现,二-LacdiNAc 三唑化合物表现出最佳性能,可使目前的蛋白受体沉淀率达到 100%,并且具有高免疫刺激活性,而没有任何引发激活诱导细胞凋亡的趋势。在所测试的化合物合成中,应用了两种酶法途径。虽然 β-N-乙酰己糖胺酶只能对两个可用受体位点中的一个进行糖基化,产率低于 10%,但人胎盘β1,4-半乳糖基转移酶-1 的 Y284L 突变体则是一种完美的合成工具,即使在两个受体位点上也能实现定量糖基化,并且对 C-4 位具有绝对区域选择性。这项工作为进一步的配体结构优化提供了新的方向,并展示了突变型人胎盘β1,4-半乳糖基转移酶-1 在合成多价糖模拟物和糖材料方面的强大合成潜力。